Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Web-Based insomnia treatment shows promise for childhood cancer survivors

NCT ID NCT04317742

Symptom relief Sponsor: St. Jude Children's Research Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested an online insomnia treatment program for adult survivors of childhood cancer. Over 1,500 survivors participated, using a web-based program that teaches healthy sleep habits and cognitive behavioral techniques. The goal was to see if improving sleep could also boost thinking skills and quality of life.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
web-based cognitive behavioral therapy for insomnia (CBT-I) program
What this could lead to
If it works, this could offer a widely accessible, scalable way to improve sleep and thinking in adult survivors of childhood cancer.
What could go wrong
This is a completed trial, but results may not apply to all survivors. The intervention is behavioral, so benefits depend on user engagement and may not be dramatic.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

1,554 people

The number who actually took part.

Started

Dec 2020

Finished

Jan 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Enrollment in CCSS * Between the ages of 18 and 65 years old * Meeting at least one of the following three insomnia criteria: * Clinically significant insomnia (i.e. score ≥8 on the Insomnia Severity Index) * Delayed sleep onset latency (SOL) (i.e. cannot get to sleep within 30 minutes, three or more times a week) * Excessive wake after sleep onset (WASO) (i.e. nighttime awakenings lasting a total of at least 30 minutes, three or more times per week) * Neurocognitive impairment (i.e. score \>84th %ile of sibling normative data in at least one domain on the CCSS-NCQ) * Regular access to the internet (at least 2-3 days per week) * Ability to read and speak English * Access to a desktop computer or a laptop * Access to a smart phone (android or iPhone), tablet or iPad with Bluetooth Low Energy BLE 4.2 or higher Exclusion Criteria: * History of a brain tumor * An irregular schedule that would prevent adoption of intervention strategies (i.e. work schedule resulting in usual bedtime earlier than 8 PM or later than 2 AM or arising time earlier than 4 AM or later than 10 AM) * Currently pregnant or breast feeding * Behavioral treatment for insomnia in the past 12 months * Diagnosis of schizophrenia or a psychotic disorder * Alcohol or drug abuse in past year * Other concurrent sleep disorders, including narcolepsy, obstructive/central sleep apnea, or restless leg syndrome * Current treatment or intervention for cognitive impairment (i.e. stimulant medication, transcranial direct current stimulation)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Childhood cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

childhood malignant neoplasm insomnia neoplasm postpoliomyelitis syndrome sleep disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Childhood cancer Insomnia Late effect Neurocognitive impairment Sleep Survivorship

Contacts and locations

Locations

  • St. Jude Children's Research Hospital

    Memphis, Tennessee, 38105, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.